0001144204-18-039106.txt : 20180720 0001144204-18-039106.hdr.sgml : 20180720 20180720131333 ACCESSION NUMBER: 0001144204-18-039106 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180719 FILED AS OF DATE: 20180720 DATE AS OF CHANGE: 20180720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DHILLON AVTAR S CENTRAL INDEX KEY: 0001260933 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-54986 FILM NUMBER: 18962084 MAIL ADDRESS: STREET 1: C/O GENETRONICS INC STREET 2: 11199 SORRENTO VALLEY ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arch Therapeutics, Inc. CENTRAL INDEX KEY: 0001537561 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 460524102 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 235 WALNUT STREET, SUITE 6 CITY: FRAMINGHAM STATE: MA ZIP: 01702 BUSINESS PHONE: 617-431-2313 MAIL ADDRESS: STREET 1: 235 WALNUT STREET, SUITE 6 CITY: FRAMINGHAM STATE: MA ZIP: 01702 FORMER COMPANY: FORMER CONFORMED NAME: ALMAH,INC DATE OF NAME CHANGE: 20111216 4/A 1 tv498917_4a.xml FORM 4/A X0306 4/A 2018-07-19 2018-07-20 1 0001537561 Arch Therapeutics, Inc. ARTH 0001260933 DHILLON AVTAR S C/O ARCH THERAPEUTICS, INC. 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 1 0 0 0 Stock Option (right to buy) 0.425 2018-07-19 4 A 0 220000 0 A 2028-07-18 Common Stock 220000 220000 D The Amount or Number of shares of Common Stock listed in Column 7 of the reporting person's original Form 4 was inadvertently listed as "200,000". The grants reported on this Statement of Changes in Beneficial Ownership on Form 4 were made in connection with that certain letter agreement dated July 19, 2018 by and between the reporting person and Arch Therapeutics, Inc. (the "Company") pursuant to which the reporting person was engaged as an advisor to the Company. The reporting person resigned from his position as a director of the Company effective as of 4:00 PM Eastern Time. Of the Shares subject to this Grant, 1/12th shall on each of the next twelve (12) monthly anniversaries of the vesting commencement date. /s/ Avtar S. Dhillon 2018-07-20